Updated Changes to USP 797 and USP 800 Pharmaceutical Compounding Guidelines and Overview
FOR MOST RECENT UPDATES AND USP CHANGES:
>> USP 795, 797, and USP 800 Revisions + Download USP Chapter Documents <<
Updated March 2018 - USP 797 Updates -
First published in 2004, USP Chapter <797> underwent new revisions as of July 2018. These revisions were previously available for public comment.
The newest <797> comment period which concluded November 30, 2018 includes a 9-point summary (below) for the pharmaceutical compounding sector.
Improvements to clarity and readability of documentation are significant for all facilities, but specifically for those compounding both hazardous (800) and non-hazardous (797) drugs, or those administering CSPs.
Production Automation often fields inquiries from small-medium sized 797 facilities who find updates required by USP 800 documentation unclear. New revisions simplify formatting and limit redundancy. General chapter (825) is also proposed for public comment.
Final revisions become official on December 1, 2019, although this date has previously been subject to change. Some sections may have longer adoption dates to allow amicable time for facility changes.
Proposed USP 797 Revisions Changes
- Reorganization of the chapter to include section and subsection numbers.
- Placement of procedural information in boxes.
- Definition of the scope of the chapter to include sterile compounding activities and exclude administration of medication (e.g., withdrawing doses for administration).
Environment Requirements and CSP Categories
- Simplified compounded sterile preparation (CSP) microbial risk levels from three (low, medium, and high) to two—Category 1 CSPs and Category 2 CSPs.
Category 1 and 2 CSPs are distinguished primarily by the facility in which they are made and the time period within which they must be used, i.e., the beyond-use date (BUD).
- Category 1 CSPs have a shorter BUD and may be prepared in an unclassified segregated compounding area (SCA).
- Category 2 CSPs have a longer BUD and must be prepared in a cleanroom suite (buffer room with ante-room).
Storage of Opened or Punctured CSP
- Addition of guidance on use and storage of opened or needle-punctured conventionally manufactured products and CSPs.
- Addition of information on notification and recall of CSPs that have out-of-specification results.
- Clarification of requirements for compounding allergenic extract prescription sets.
- Removal of information related to the handling of hazardous drugs and addition of references to Hazardous Drugs—Handling in Healthcare Settings 〈800〉.
Removal of Radiopharmaceuticals Section from USP 797
- Removal of the section on radiopharmaceuticals as CSPs and addition of a reference to Radiopharmaceuticals—Preparation, Compounding, Dispensing, and Repackaging 〈825〉. General chapter 〈825〉 is also proposed for public comment in PF 44(5).
Need Help Upgrading a Cleanroom for USP 800 Standards?
We help industrial, government, and enterprise customers target a specific cleanroom classification or isolate an operation to keep it cleaner.
Related Posts
-
USP <800> Compounding Cleanrooms
Updated: USP 800 is a cleanroom standard issued in March of 2014 by the United States Pharmacopeial Convention (USP). The deadline December 2019 for compliance may change.
-
USP 797 Guidelines: Sterile Compounding Cleanroom Design, Components, and Procedure
USP Chapter 797 cleanroom design requires that facilities pressurize non-hazardous compounding and storage areas. ISO 5, 7 and 8 environments support primary engineering controls, buffer rooms, and ante-rooms. Updated: 4/18/2019
-
Cleanroom and Sterile Compounding Glossary and Definitions
The definitive cleanroom and sterile compounding glossary. Learn terminology and definitions for USP 797 and USP 800 compounding.
-
CleanPro® Chemotherapy & CSP Cleanroom Installation
This modular, sterile compounding cleanroom is designed for USP 797 and USP 800 compliance, particularly for compounding chemotherapy drugs. Safe handling of sterile compounds requires special considerations: heat-welded floors, anterooms and buffer areas.
-
Upgrading a USP 797 Cleanroom to USP 800?
New USP guidelines may present challenges for compounding facilities. Some facilities need infrastructural and mechanical modifications for compliance. System evaluation includes duct systems, HEPA fan filters, differential pressure standards, air monitoring, and external air exhaust…
-
USP Posts Revised PDFs for USP 795, 797, 800, 825 - Updated November 2019
Updated November 2019: Where can I find updated USP 800, 797, and other compounding documentation? Are there any recent changes to USP documents? When is the official deadline for USP 800 compliance?